306 related articles for article (PubMed ID: 18375050)
1. Function and expression of somatostatin receptors of the endocrine pancreas.
Strowski MZ; Blake AD
Mol Cell Endocrinol; 2008 May; 286(1-2):169-79. PubMed ID: 18375050
[TBL] [Abstract][Full Text] [Related]
2. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
Hofsli E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas.
RamÃrez JL; Grant M; Norman M; Wang XP; Moldovan S; de Mayo FJ; Brunicardi C; Kumar U
Mol Cell Endocrinol; 2004 Jun; 221(1-2):105-19. PubMed ID: 15223137
[TBL] [Abstract][Full Text] [Related]
4. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis.
Rajput PS; Billova S; Patel SC; Kharmate G; Somvanshi RK; Kumar U
J Chem Neuroanat; 2009 Sep; 38(1):20-33. PubMed ID: 19465111
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonist.
Strowski MZ; Cashen DE; Birzin ET; Yang L; Singh V; Jacks TM; Nowak KW; Rohrer SP; Patchett AA; Smith RG; Schaeffer JM
Endocrinology; 2006 Oct; 147(10):4664-73. PubMed ID: 16857751
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin analogs in the treatment of neuroendocrine gastroenteropancreatic and intrathoracic tumors.
Janson ET
J Endocrinol Invest; 2005; 28(11 Suppl International):137-40. PubMed ID: 16625863
[TBL] [Abstract][Full Text] [Related]
7. Biology of somatostatin in breast cancer.
Watt HL; Kharmate G; Kumar U
Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465
[TBL] [Abstract][Full Text] [Related]
8. Future aspects of somatostatin-receptor-mediated therapy.
Oberg K
Neuroendocrinology; 2004; 80 Suppl 1():57-61. PubMed ID: 15477719
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin and its receptors in the development of the endocrine pancreas.
Ballian N; Brunicardi FC; Wang XP
Pancreas; 2006 Jul; 33(1):1-12. PubMed ID: 16804406
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
Strowski MZ; Parmar RM; Blake AD; Schaeffer JM
Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin and the gastrointestinal tract.
Corleto VD
Curr Opin Endocrinol Diabetes Obes; 2010 Feb; 17(1):63-8. PubMed ID: 19907319
[TBL] [Abstract][Full Text] [Related]
12. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptors and autoimmune-mediated diabetes.
Wang XP; Norman MA; Brunicardi FC
Diabetes Metab Res Rev; 2005; 21(1):15-30. PubMed ID: 15624122
[TBL] [Abstract][Full Text] [Related]
14. The somatostatin receptor subtype 5 in neuroendocrine tumours.
van der Hoek J; Lamberts SW; Hofland LJ
Expert Opin Investig Drugs; 2010 Mar; 19(3):385-99. PubMed ID: 20151855
[TBL] [Abstract][Full Text] [Related]
15. Prolonged somatostatin therapy may cause down-regulation of SSTR-like GPCRs on Schistosoma mansoni.
Chatterjee S; Op De Beeck J; Rao AV; Desai DV; Vrolix G; Rylant F; Panis T; Bernat A; Van Bergen J; Peeters D; Van Marck E
J Vector Borne Dis; 2007 Sep; 44(3):164-80. PubMed ID: 17896619
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor subtypes in human type 2 diabetic islets.
Portela-Gomes GM; Grimelius L; Westermark P; Stridsberg M
Pancreas; 2010 Aug; 39(6):836-42. PubMed ID: 20182388
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727.
Ono K; Suzuki T; Miki Y; Taniyama Y; Nakamura Y; Noda Y; Watanabe M; Sasano H
Anticancer Res; 2007; 27(4B):2231-9. PubMed ID: 17695508
[TBL] [Abstract][Full Text] [Related]
18. The role of somatostatin analogues in the treatment of neuroendocrine tumours.
Grozinsky-Glasberg S; Grossman AB; Korbonits M
Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
20. The role of somatostatin and dopamine D2 receptors in endocrine tumors.
Gatto F; Hofland LJ
Endocr Relat Cancer; 2011 Dec; 18(6):R233-51. PubMed ID: 22135243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]